AKEBIA THERAPEUTICS, INC. Payments of Stock Issuance Costs
AKEBIA THERAPEUTICS, INC. (AKBA) reported Payments of Stock Issuance Costs of $1.68 million for the 85-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2014-08-11
- AKEBIA THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2013-06-30 was $1.14M.
- AKEBIA THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2013-03-31 was $17.35K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 85 month |
|---|---|---|---|
| 2014-03-31 | $1.68M 10-Q · filed 2014-05-12 | ||
| 2013-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.15M 10-Q · filed 2014-08-11 | |
| 2013-03-31 | $17.35K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |